First Patient Dosed in First Ever Phase 3 Clinical Trial for Celiac Disease
On August 13th, 2019, Innovate Biopharmaceuticals, Inc. (Innovate) announced the first patient has been dosed in its Phase 3 clinical trial for patients with celiac disease. The CeD LA 3001…
Continue Reading